Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Clinical trial NCT02013531 · COMPLETED
Trial details
- NCT number
- NCT02013531
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2014-05-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.